A multifactorial intervention strategy to target various risk factors in diabetic patients is important as the prevalence and causes of kidney disease in diabetic patients rises. The potential benefits of new class of drugs such as SGLT2-is that target the cardio renal metabolic systems have efficacy in showing the reduction of albuminuria and the protection of renal outcomes.